CivaDerm(TM) Surface Therapy Pilot Study
Who is this study for? Patients with Basal Cell Carcinoma, Squamous Cell Carcinoma
What treatments are being studied? CivaDerm
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
This is a pilot study to determine the usefulness of new brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit basal cell and squamous cell carcinoma patients by providing conformal radiation therapy to the surface of the skin.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• subject signed informed consent
• Confirmed superficial or nodular basal cell or squamous cell carcinoma
• Biopsy proven on chest, stomach, back, arms, legs, feet (trunk and extremities)
• \>5 mm of residual tumor
• tumors \< 3 cm
• Capable of complying with Patient Release Instructions
Locations
United States
North Carolina
CivaDerm Oncology PLLC
RECRUITING
Morrisville
Contact Information
Primary
Kristy Perez, PhD
kperez@civatechoncology.com
9193145515
Backup
Carra Castagnero
clinical@civatechoncology.com
9193145515
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2026-04-30
Participants
Target number of participants: 10
Treatments
Experimental: Treatment
Radioactive bandage applied to surface of the body worn for approximately one week.
Authors
Related Therapeutic Areas
Sponsors
Leads: CivaTech Oncology